SKI Market

Indian Indices

Sensex

80,015.90 899.71
( 1.14%)

Global Indices

Nasdaq

48,766.17 243.89
(0.50%)

Dow Jones

6,891.51 53.88
(0.79%)

Hang Seng

55,141.42 895.88
(1.65%)

Nikkei 225

10,568.52 84.39
(0.80%)

Forex

USD-INR

91.96 0.48
(0.52%)

EUR-INR

106.94 -0.34
(-0.32%)

GBP-INR

122.70 0.09
(0.07%)

JPY-INR

0.58 0.00
(0.18%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5552288

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

23.14

106033.33

EPS(TTM)

Face Value()

Div & Yield %

56.72

1.22

Back

cipla ltd

Cipla consolidated net profit declines 56.97% in the December 2025 quarter

Jan 23,2026

Net profit of Cipla declined 56.97% to Rs 675.80 crore in the quarter ended December 2025 as against Rs 1570.51 crore during the previous quarter ended December 2024. Sales rose 0.02% to Rs 6962.97 crore in the quarter ended December 2025 as against Rs 6961.60 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	6962.97	6961.60	0
OPM %	18.02	28.57	-
PBDT	1447.37	2195.89	-34
PBT	1169.02	1916.09	-39
NP	675.80	1570.51	-57

80,015.90 899.71 ( 1.14%)

48,766.17 243.89 (0.50%)

6,891.51 53.88 (0.79%)

55,141.42 895.88 (1.65%)

10,568.52 84.39 (0.80%)

91.96 0.48 (0.52%)

106.94 -0.34 (-0.32%)

122.70 0.09 (0.07%)

0.58 0.00 (0.18%)